Aspirin may reduce bowel cancer deaths

Long-term daily use of 75 mg aspirin may reduce the long-term incidence of bowel cancer by a quarter, and deaths by a third, according to research published in The Lancet.

The longer the period that patients took the aspirin, the greater the reduction in colorectal cancer risk, the researchers found. The authors claimed that administering aspirin for five years or longer reduced risk of proximal colon cancer by around 70%.

 

Latest Issues

AfPP Regional Conference – Nottingham

Business School, University of Nottingham
20th September 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025

AfPP Regional Conference – Oxford

Mathematical Institute, University of Oxford
4th October 2025

BACCN Conference 2025

Blackpool
7th - 8th October 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025